Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 522.93 billion as of April 1, 2025. Its market cap has decreased by -35.78% in one year.

Market Cap

522.93B

Enterprise Value

545.87B

Revenue

15.05B

Ranking

n/a

PE Ratio

n/a

Stock Price

10,890.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 522.93B, an increase of 1,001.04%. That is a compound annual growth rate of 11.47%.

Market Cap History

Date	Market Cap	% Change
Apr 1, 2025	522.93B	-6.93%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1,038.98B	-4.44%
Dec 29, 2022	1,087.24B	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	1,048.68B	115.45%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.17T
Celltrion	36.29T
ALTEOGEN	18.97T
Yuhan	8,178.75B
SK Biopharmaceuticals	7,933.13B
HLB Co., Ltd.	7,605.62B
Sam Chun Dang Pharm.	4,049.13B
PharmaResearch	3,636.38B

Market Cap Rankings